Hemodynamic Monitoring Systems Market - Forecasts from 2018 to 2023
In 2023, the market for hemodynamic monitoring systems is expected to reach US$669.05 million in 2017, increasing from US$917.28 million. During this period, it is projected to grow at a CAGR of 5.40%. Hemodynamic is a part of cardiovascular physiology which deals with blood circulation through the cardiovascular system. Hemodynamic monitoring systems help monitor adequate blood flow thus helping secure cardiovascular health, survival of patients post-surgery, longevity, and quality of life. Benefits of such a system include the elimination of repetitive data entry and data accessibility from different locations. Demand for such systems has risen significantly in recent years as various lifestyle-related factors have an increasing number of people suffering from hypertension and diabetes. Technological advancement and innovations in medical treatment have fuelled further growth. Geographically, North America is estimated to account for the largest market share over the projected period while the Asia Pacific is expected to witness’s highest growth.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the pressure sensors value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the market.
Major industry players profiled as part of the report are GE Healthcare, Pulsion Medical Systems SE, Cheetah Medical, Inc., Philips Healthcare, and Edward Lifesciences among others.
Segmentation
The Hemodynamic Monitoring Systems market has been analyzed through following segments:
By Type
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the pressure sensors value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the market.
Major industry players profiled as part of the report are GE Healthcare, Pulsion Medical Systems SE, Cheetah Medical, Inc., Philips Healthcare, and Edward Lifesciences among others.
Segmentation
The Hemodynamic Monitoring Systems market has been analyzed through following segments:
By Type
- Non- Invasive
- Minimally- Invasive
- Invasive
- Monitoring Instruments
- Disposables
- Hospitals and Clinics
- Laboratories
- Homecare and Ambulatory Sites
- North America
- South America
- Europe
- Middle East and Africa
- Asia Pacific
- Manufacturers
- Suppliers
- Distributors
- Service Providers
- Government Agencies
- Research Organizations
- Consultants
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. HEMODYNAMIC MONITORING SYSTEMS MARKET BY TYPE
5.1. Non- Invasive
5.2. Minimally- Invasive
5.3. Invasive
6. HEMODYNAMIC MONITORING SYSTEMS MARKET BY TYPE OF SOLUTION
6.1. Monitoring Instruments
6.2. Disposables
7. HEMODYNAMIC MONITORING SYSTEMS MARKET BY TYPE OF END USER
7.1. Hospitals and Clinics
7.2. Laboratories
7.3. Homecare and Ambulatory Sites
8. HEMODYNAMIC MONITORING SYSTEMS MARKET BY GEOGRAPHY
8.1. North America
8.2. South America
8.3. Europe
8.4. Middle East and Africa
8.5. Asia Pacific
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Investment Analysis
9.3. Recent Deals
9.4. Strategies of Key Players
10. COMPANY PROFILES
10.1. Edward Lifesciences
10.1.1. Company Overview
10.1.2. Financials
10.1.3. Products and Services
10.1.4. Recent Developments
10.2. GE Healthcare
10.2.1. Company Overview
10.2.2. Financials
10.2.3. Products and Services
10.2.4. Recent Developments
10.3. Philips Healthcare
10.3.1. Company Overview
10.3.2. Financials
10.3.3. Products and Services
10.3.4. Recent Developments
10.4. Drager Medical GmbH
10.4.1. Company Overview
10.4.2. Financials
10.4.3. Products and Services
10.4.4. Recent Developments
10.5. LiDCO Group PLC
10.5.1. Company Overview
10.5.2. Financials
10.5.3. Products and Services
10.5.4. Recent Developments
10.6. Pulsion Medical Systems SE
10.6.1. Company Overview
10.6.2. Financials
10.6.3. Products and Services
10.6.4. Recent Developments
10.7. ICU Medical, Inc.
10.7.1. Company Overview
10.7.2. Financials
10.7.3. Products and Services
10.7.4. Recent Developments
10.8. Cheetah Medical, Inc.
10.8.1. Company Overview
10.8.2. Financials
10.8.3. Products and Services
10.8.4. Recent Developments
10.9. CN Systems Medizintechnik AG
10.9.1. Company Overview
10.9.2. Financials
10.9.3. Products and Services
10.9.4. Recent Developments
10.10. Schwarzer Cardiotek
10.10.1. Company Overview
10.10.2. Financials
10.10.3. Products and Services
10.10.4. Recent Developments
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. HEMODYNAMIC MONITORING SYSTEMS MARKET BY TYPE
5.1. Non- Invasive
5.2. Minimally- Invasive
5.3. Invasive
6. HEMODYNAMIC MONITORING SYSTEMS MARKET BY TYPE OF SOLUTION
6.1. Monitoring Instruments
6.2. Disposables
7. HEMODYNAMIC MONITORING SYSTEMS MARKET BY TYPE OF END USER
7.1. Hospitals and Clinics
7.2. Laboratories
7.3. Homecare and Ambulatory Sites
8. HEMODYNAMIC MONITORING SYSTEMS MARKET BY GEOGRAPHY
8.1. North America
8.2. South America
8.3. Europe
8.4. Middle East and Africa
8.5. Asia Pacific
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Investment Analysis
9.3. Recent Deals
9.4. Strategies of Key Players
10. COMPANY PROFILES
10.1. Edward Lifesciences
10.1.1. Company Overview
10.1.2. Financials
10.1.3. Products and Services
10.1.4. Recent Developments
10.2. GE Healthcare
10.2.1. Company Overview
10.2.2. Financials
10.2.3. Products and Services
10.2.4. Recent Developments
10.3. Philips Healthcare
10.3.1. Company Overview
10.3.2. Financials
10.3.3. Products and Services
10.3.4. Recent Developments
10.4. Drager Medical GmbH
10.4.1. Company Overview
10.4.2. Financials
10.4.3. Products and Services
10.4.4. Recent Developments
10.5. LiDCO Group PLC
10.5.1. Company Overview
10.5.2. Financials
10.5.3. Products and Services
10.5.4. Recent Developments
10.6. Pulsion Medical Systems SE
10.6.1. Company Overview
10.6.2. Financials
10.6.3. Products and Services
10.6.4. Recent Developments
10.7. ICU Medical, Inc.
10.7.1. Company Overview
10.7.2. Financials
10.7.3. Products and Services
10.7.4. Recent Developments
10.8. Cheetah Medical, Inc.
10.8.1. Company Overview
10.8.2. Financials
10.8.3. Products and Services
10.8.4. Recent Developments
10.9. CN Systems Medizintechnik AG
10.9.1. Company Overview
10.9.2. Financials
10.9.3. Products and Services
10.9.4. Recent Developments
10.10. Schwarzer Cardiotek
10.10.1. Company Overview
10.10.2. Financials
10.10.3. Products and Services
10.10.4. Recent Developments
